Background Venous thromboembolism (VTE) is a common postoperative complication in
patients undergoing surgery for gastric cancer (GC). Although VTE incidence may vary …

Clinical data mining of predictive models offers significant advantages for re-evaluating and
leveraging large amounts of complex clinical real-world data and experimental comparison …

Hospitalisation with an acute medical illness represents a significant risk factor for venous
thromboembolism. Identification of patients at high risk of VTE at hospital admission and …

Simple Summary Cancer-associated thrombosis (CAT) is a severe cause of mortality and
morbidity in cancer patients, while active cancer is present in 20% of all patients with venous …

Hospital‐associated venous thromboembolism (VTE) is defined as any case of VTE
occurring during hospital admission and for up to 90 days post discharge. It accounts for …

Cancer-associated thrombosis is the second leading cause of death in cancer patients, and
its incidence has been increasing in recent years. This survey was aimed at gathering …

Background Over the past 2 decades, advances in systemic therapy, including molecularly
targeted treatments and immune checkpoint inhibitors (ICIs), have transformed the …

Abstract Background The mechanism of Venous thromboembolism (VTE) is complicated
and difficult to prevent due to factors such as bone marrow invasion, therapy, and immune …

OBJECTIVES Serum matrix metalloproteinase (MMP) levels are associated with
cardiovascular diseases. However, the causal associations between serum levels of specific …

Background Venous thromboembolism is a preventable complication of gynecologic cancer
surgery that leads to postoperative morbidity and mortality. This study compared apixaban …